21 – 30 of 150
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Neutrophil infiltration in peritoneal metastasis affects prognosis in patients with ovarian cancer
- Contribution to journal › Article
-
Mark
Fusions4U: a resource of validated and annotated gene fusions in 328 cancer cell lines
(2025) In BMC Cancer
- Contribution to journal › Article
-
Mark
Maintenance olaparib monotherapy in patients with platinum-sensitive relapsed ovarian cancer without a germline BRCA1 and/or BRCA2 mutation : Final overall survival results from the OPINION trial
- Contribution to journal › Article
-
Mark
Long-term prognostic significance of ascites cytology in ovarian cancer cases in which R0 resection was achieved in the initial surgery : A multi-institutional retrospective cohort study
- Contribution to journal › Article
-
Mark
Stand-alone transcriptional immune response prediction in primary triple-negative breast cancer
- Contribution to journal › Article
-
Mark
Transplacental sirolimus : a new treatment strategy for life-threatening fetal cardiac rhabdomyomas—a case report
- Contribution to journal › Letter
-
Mark
Primary treatment and survival in malignant ovarian germ cell tumors : A nationwide population-based Swedish Gynecologic Cancer Group (SweGCG) study
- Contribution to journal › Article
-
Mark
The multidimensional role of laminin γ2 (LAMC2) on cancer progression
- Contribution to journal › Scientific review
- 2024
-
Mark
Kataegis in clinical and molecular subgroups of primary breast cancer
(2024) European Association for Cancer Research
- Contribution to conference › Poster
-
Mark
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer
- Contribution to journal › Article
